Drug intelligence / Profile preview

dexketoprofen + tramadol

Development stage
Phase 4
Lead developer
Menarini Ricerche
Modality
Small Molecules
Administration
Oral
01

Overview

Dexketoprofen + tramadol is a fixed-dose combination analgesic containing two active pharmaceutical ingredients: dexketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX)-1 and COX‑2 to reduce prostaglandin synthesis, and tramadol, a centrally acting synthetic opioid analgesic that acts as a partial agonist at μ-opioid receptors and inhibits the reuptake of norepinephrine and serotonin. The combination is designed for the short-term symptomatic treatment of moderate to severe acute pain in adults. Dexketoprofen provides rapid onset anti-inflammatory and analgesic effects, while tramadol offers central pain relief with additional monoaminergic activity. The combination has been shown to provide synergistic pain relief with an improved safety profile compared to higher doses of individual components[2][4][5][8].

Brand names
SkudexumLenizakSkudex
Other names
dexketoprofen trometamol/tramadol hydrochloridedexketoprofen/tramadol hydrochloridetramadol/dexketoprofen trometamol
02

Targets

σR (Sigma receptors)SERT (Sodium-dependent serotonin transporter)MOR (Mu opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)KOR (Kappa opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on dexketoprofen + tramadol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dexketoprofen + tramadol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call